Conformal Chemoradiation for Primary and Metastatic Liver Malignancies

Seminars in Surgical Oncology

Volumn 21, Issue 4, 2003, Pages 249-255

  Dawson, Laura A ^a   McGinn, Cornelius J ^b   Lawrence, Theodore S ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chemoradiation; Conformal radiation; Liver cancer

Indexed keywords

FLOXURIDINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DOSE RESPONSE; HEPATOBILIARY SYSTEM CANCER; HUMAN; LIVER CARCINOMA; LIVER METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; RADIOTHERAPY, CONFORMAL;

EID: 0347384238     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.10043     Document Type: Review

References (51)

1. Weiss L, Grundmann E, Torhorst J, et al: Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
2. O'Connell MJ, Nagorney DM, Bernath AM, et al: Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 1998;16:2528-2533.
3. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278-284.
4. Allgaier HP, Deibert P, Olschewski M, et al: Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - a single-center analysis including 132 patients. Int J Cancer 1998;79:601-605.
5. Giorgio A, Tarantino L, Mariniello N, et al: Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients. Eur J Ultrasound 1998;8:201-206.
6. Pergolizzi JV Jr, Auster M, Conaway GL, et al: Cryosurgery for unresectable primary hepatocellular carcinoma: a case report and review of literature [Review]. Am Surgeon 1999;65:402-405.
7. Sheen AJ, Poston GJ. Sherlock DJ: Cryotherapeutic ablation of liver tumours. British Journal of Surgery 2002;89:1396-1401.
8. Rhim H, Dodd GD 3rd: Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-229.
9. Murakami T, Shibata T, Ishida T, et al: Percutaneous microwave hepatic tumor coagulation with segmental hepatic blood flow occlusion in seven patients. AJR Am J Roentgenol 1999;172:637-640.
10. Ingold J, Reed G, Kaplan H: Radiation hepatitis. AJR Am J Roentgenol 1965;93:200-208.
11. Wharton JT, Delclos L, Gallager S, et al: Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 1973;117: 73-80.
12. Matsuzaki Y, Osuga T, Chiba T, et al: New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Internal Med 1995;34:302-304.
13. Robertson JM, McGinn CJ, Walker S, et al: A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys 1997;39:1087-1092.
14. Robertson JM, Lawrence TS, Walker S, et al: The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys 1995;32: 445-450.
15. Ohara K, Okumura T, Tsuji H, et al: Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int J Radiat Oncol Biol Phys 1997;38:367-372.
16. Lawrence TS, Robertson JM, Anscher MS, et al: Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31:1237-1248.
17. Ten Haken RK, Lawrence TS, McShan DL, et al: Technical considerations in the use of 3-D beam arrangements in the abdomen. Radiother Oncol 1991;22:19-28.
18. Matsuura M, Nakajima N, Arai K, et al: The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology 1998;45:791-796.
19. Dawson L, McGinn C, Normolle D, et al: Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000;18: 2210-2218.
20. Lawrence TS, Ten Haken RK, Kessler ML, et al: The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992;23:781-788.
21. Ohara K, Okumura T, Tsuji H, et al: Clearance of parenchymal tumors following radiotherapy: analysis of hepatocellular carcinomas treated by proton beams. Radiother Oncol 1996;41:233-236.
22. Breedis C, Young C: The blood supply of neoplasm in the liver. Am J Pathol 1954:30:969-974.
23. Sigurdson ER, Ridge JA, Kemeny N, et al: Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987;5:1836-1840.
24. Ensminger WD: Regional chemotherapy. Semin Oncol 1993;20: 3-11.
25. Meta-analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-258.
26. Harmantas A, Rotstein LE, Langer B: Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer 1996;78:1639-1645.
27. Russell AH, Clyde C, Wasserman TH, et al: Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 1993;27:117-123.
28. Leibel SA, Pajak TF, Massullo V, et al: A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 1987;13:1057-1064.
29. Borgelt BB, Gelber R, Brady LW, et al: The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 1981;7:587-591.
30. Schacter L, Crum E, Spitzer T, et al: Fatal radiation hepatitis: a case report and review of the literature. Gynecol Oncol 1986;24: 373-380.
31. Haddad E, Le Bourgeois JP, Kuentz M, et al: Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results. Int J Radiat Oncol Biol Phys 1983;9:13131-319.
32. McCracken JD, Weatherall TJ, Oishi N, et al: Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. Cancer Treat Rep 1985;69:129-131.
33. Lawrence T, Tepper J, Blackstock A: Fluoropyrimidine-radiation interactions in cells and tumors. Semin Radiat Oncol 1997;7:260-266.
34. Lawrence TS, Dworzanin LM, Walker-Andrews SC, et al: Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys 1991;20:555-561.
35. Ten Haken RK, Martel MK, Kessler ML, et al: Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 1993;27:689-695.
36. McGinn CJ, Ten Haken RK, Ensminger WD, et al: Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998;16:2246-2252.
37. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53: 810-821.
38. Mohiuddin M, Chen E, Ahmad N: Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996;14:722-728.
39. Blomgren H, Lax I, Naslund I, et al: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
40. Uematsu M, Shioda A, Suda A, et al: Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit. Int J Radiat Oncol Biol Phys 2000;48:443-448.
41. Herfarth KK, Debus J, Lohr F, et al: Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:164-170.
42. Sitzmann JV, Abrams R: Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 1993;217:149-154.
43. Chen SC, Lian SL, Chuang WL, et al: Radiotherapy in the treatment of hepatocellular carcinoma and its metastases. Cancer Chemother Pharmacol 1992;31(Suppl):S103-105.
44. Stillwagon GB, Order SE, Guse C, et al: 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys 1989;17:1223-1229.
45. Stillwagon GB, Order SE, Guse C, et al: Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group study 83-01. Int J Radiat Oncol Biol Phys 1991;20:65-71.
46. Robertson JM, Lawrence TS, Dworzanin LM, et al: Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 1993;11:1286-1293.
47. Aoki K, Okazaki N, Okada S, et al: Radiotherapy for hepatocellular carcinoma: clinicopathological study of seven autopsy cases. Hepatogastroenterology 1994;41:427-431.
48. Ausili Cefaro GP, Cellini N, Basilico L: Role of radiotherapy in the treatment of hepatocellular carcinoma. Rays 1990;15:423-431.
49. Cheng JC, Chuang VP, Cheng SH, et al: Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2000;47:435-442.
50. Dawson LA, Brock KK, Kazanjian S, et al: The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:1410-1421.
51. Symon Z, Levi M, Ensminger WD, Smith DE, Lawrence TS: Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model. Int J Radiat Oncol Biol Phys 2001;50:473-478.